Tom Wilemon

(iStock)
October 4, 2024

‘Off-the-shelf’ CAR-T therapy shows promise for relapsed/refractory multiple myeloma 

The therapy, P-BCMA-ALL01, demonstrated a 91% overall response rate for the 23 patients participating in the phase 1 trial.

By Tom Wilemon
October 2, 2024

Grant funds quest to expand immunotherapy efficacy for colorectal cancer  

The study seeks to understand the mechanisms of colorectal cancer and builds on recent Vanderbilt research.

By Tom Wilemon
Patient Kathy Wilcox, here with her husband, John, is an avid flyer with an indefatigable zest for life; a quality that has not been shaken by her cancer diagnoses.
September 27, 2024

Vanderbilt-Ingram Cancer Center part of new ‘Rewriting Cancer’ series

Launched Sept. 17-19 during the World Cancer Congress in Geneva, Switzerland, “Rewriting Cancer” aims to enhance understanding and inspire audiences by exploring the most innovative, inclusive and impactful solutions for cancer prevention, diagnosis, treatment and care globally.

By Tom Wilemon
September 20, 2024

Vanderbilt researchers speaks at World Conference on Lung Cancer

Deppen spoke about biological, population and technology issues related to the discovery and implementation of biomarkers for early cancer detection.

By Tom Wilemon
(iStock)
September 17, 2024

Protocol improves follow-up for women at high risk for breast cancer 

Before the protocol, every patient underwent a Breast Cancer Risk Assessment Tool evaluation, yet there was no established protocol for sharing the results.

By Tom Wilemon
(iStock)
August 28, 2024

Vanderbilt and OHSU join forces to train addiction research scholars 

The new training program’s participants will focus their research efforts on substance use with an emphasis on vulnerable populations, such as people living with HIV.

By Tom Wilemon
July 30, 2024

Friend’s cancer diagnosis inspired Tracey DeWire to change career path

Nominated by four patients, DeWire is a recipient of a 2024 Patient and Family Choice Award.
By Tom Wilemon
July 25, 2024

Cookeville celebration

Vanderbilt-Ingram Cancer Center celebrated a ribbon cutting recently  at the Cookeville Regional Medical Center Cancer Center, where Vanderbilt-Ingram medical oncologists, radiation oncologists and advanced practice nurses are now the exclusive providers for cancer care.
By Tom Wilemon
July 10, 2024

Clinical trial for rectal cancer subtype shows promise for less aggressive treatment

The findings were so promising that the clinical trial is being redesigned to investigate whether radiation treatment can also be avoided.
By Tom Wilemon
June 21, 2024

International overview of colorectal cancer provides multidisciplinary perspective of clinical advances

The authors hope the report will provide insight on the importance of education, screening and awareness to all health care providers.
By Tom Wilemon
June 19, 2024

Study of messenger RNA regulatory mechanism reveals cancer risk genes

The Vanderbilt study used RNA-sequencing data generated in multiple normal tissues, along with matched genotype data from the Genotype-Tissue Expression Project as well as large-scale genomic data for cancers of the breast, ovary, prostate, colorectum, lung and pancreas.
By Tom Wilemon
June 6, 2024

Vanderbilt-Ingram Cancer Center’s clinicians will staff the Cancer Center at Cookeville Regional Medical Center

Through this agreement Vanderbilt-Ingram Cancer Center’s medical oncologists, radiation oncologists and advanced practice nurses will be Cookeville Regional’s exclusive providers of cancer services.
By Tom Wilemon
1 2 3 4 … 37